Literature DB >> 11757077

Autoimmune gestational diabetes mellitus: a distinct clinical entity?

D Mauricio1, A de Leiva.   

Abstract

This review gives an update of the present knowledge on what is defined here as autoimmune gestational diabetes mellitus (GDM). Autoimmune phenomena associated with type 1 diabetes mellitus (DM) can be detected in a subgroup of women with GDM. Islet autoantibodies are present in sera from women with GDM with variable frequency. Distinct phenotypic and genotypic features may be recognised in this subset of women with GDM, which are representative of a distinct clinical entity. Furthermore, these women are at increased risk of developing type 1 DM after pregnancy. However, the eventual progression of the autoimmune destruction of beta-cells in these subjects may follow different time-course patterns thus leading to variable forms of presentation of autoimmune DM. As a high-risk group for type 1 diabetes, women with previous autoimmune GDM may be candidates for potential immune intervention strategies. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757077     DOI: 10.1002/dmrr.237

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  7 in total

Review 1.  Autoimmunity and familial risk of type 1 diabetes.

Authors:  Anu-Maaria Hämäläinen; Mikael Knip
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

2.  Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Pooja Mittal; Zhong Dong; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

3.  Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up.

Authors:  E Cossu; M Incani; M G Pani; G Gattu; C Serafini; A Strazzera; L Bertoccini; F A Cimini; I Barchetta; M G Cavallo; M G Baroni
Journal:  J Endocrinol Invest       Date:  2018-01-16       Impact factor: 4.256

4.  Gestational diabetes mellitus and later cardiovascular disease: a Swedish population based case-control study.

Authors:  H Fadl; A Magnuson; I Östlund; S Montgomery; U Hanson; E Schwarcz
Journal:  BJOG       Date:  2014-04-25       Impact factor: 6.531

5.  The relationships between HLA class II alleles and antigens with gestational diabetes mellitus: A meta-analysis.

Authors:  Cong-Cong Guo; Yi-Mei Jin; Kenneth Ka Ho Lee; Guang Yang; Chun-Xia Jing; Xuesong Yang
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

6.  Microarray analysis of differentially expressed genes and their functions in omental visceral adipose tissues of pregnant women with vs. without gestational diabetes mellitus.

Authors:  Yuan Qian; Hao Sun; Hongli Xiao; Meirun Ma; Xue Xiao; Qinzai Qu
Journal:  Biomed Rep       Date:  2017-03-22

7.  Epigenome-wide and transcriptome-wide analyses reveal gestational diabetes is associated with alterations in the human leukocyte antigen complex.

Authors:  Alexandra M Binder; Jessica LaRocca; Corina Lesseur; Carmen J Marsit; Karin B Michels
Journal:  Clin Epigenetics       Date:  2015-08-05       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.